Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06497933

Exhaustive French National Registry of AF Ablation Using Pentaspline Pulsed Field Ablation Catheter

Exhaustive French National Online Registry of Atrial Fibrillation Ablation Procedures Using the Pentaspline Pulsed Field Ablation Catheter

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
5,223 (actual)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pulsed field ablation (PFA) is a nonthermal ablative modality using a strong electrical field created around a dedicated catheter to produce pores in the cellular membrane. As the amount of energy required to produce electroporation is highly tissue dependent, the atrial myocardium can be specifically targeted while sparing adjacent tissues. This new ablation modality could increase the safety of pulmonary vein isolation (PVI) procedures compared to PVI using thermal energies. The investigators aim to provide the first exhaustive Nationwide registry using the pentaspline PFA catheter to treat atrial fibrillation patients.

Detailed description

This is a multicenter observational research project, that prospectively included patients undergoing a first time atrial fibrillation ablation using the Farapulse technology (Boston Scientific) since the start of this technology in France. All patients treated with the Farapulse technology for atrial fibrillation in France from March 2021 to February 29th of 2024 will be included in the registry. The number of participating centers is 33. A one-year and 2-year follow-up will be performed according to the standard practices of the different centers. The study duration will be 5 years.

Conditions

Interventions

TypeNameDescription
PROCEDUREAtrial fibrillation ablationPulmonary veins isolation potentially associated with other atrial lesions, performed with the pentaspline PFA catheter

Timeline

Start date
2021-03-01
Primary completion
2023-03-01
Completion
2026-03-01
First posted
2024-07-12
Last updated
2024-07-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06497933. Inclusion in this directory is not an endorsement.